KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Moderna (MRNA) Amortizatization of Intangibles (2018 - 2026)

Moderna (MRNA) has disclosed Amortizatization of Intangibles for 9 consecutive years, with $11.0 million as the latest value for Q1 2026.

  • For Q1 2026, Amortizatization of Intangibles fell 42.11% year-over-year to $11.0 million; the TTM value through Mar 2026 reached $59.0 million, down 32.18%, while the annual FY2025 figure was $67.0 million, 29.47% down from the prior year.
  • Amortizatization of Intangibles hit $11.0 million in Q1 2026 for Moderna, down from $13.0 million in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $28.0 million in Q2 2024 and bottomed at -$18.0 million in Q1 2022.
  • Average Amortizatization of Intangibles over 5 years is $11.9 million, with a median of $17.0 million recorded in 2023.
  • Year-over-year, Amortizatization of Intangibles plummeted 260.0% in 2022 and then skyrocketed 400.0% in 2023.
  • Moderna's Amortizatization of Intangibles stood at $4.0 million in 2022, then surged by 400.0% to $20.0 million in 2023, then decreased by 5.0% to $19.0 million in 2024, then crashed by 31.58% to $13.0 million in 2025, then dropped by 15.38% to $11.0 million in 2026.
  • According to Business Quant data, Amortizatization of Intangibles over the past three periods came in at $11.0 million, $13.0 million, and $17.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.